CDKN1C and cancer: Next, we investigated in SKP2/N-RasV12 lesions the levels of tumor suppressors that have been shown to be inactivated in cancer via SKP2-dependent proteolysis, including p27, p57, Dusp1, and Rassf1A [16-21], by immunohistochemistry.